534595-53-4 Usage
Uses
Used in Pharmaceutical Industry:
N-isopropylpiperidin-4-amine is used as an intermediate in the synthesis of 6-substituted benzoxazines. These benzoxazines serve as 5-HT5A antagonists, which are crucial for the treatment of various mental disorders. By modulating the serotonin 5-HT5A receptors, these antagonists can help alleviate symptoms associated with mental health conditions.
Used in Preparation of Antagonists:
N-isopropylpiperidin-4-amine is utilized as a key component in the preparation of 6-substituted benzoxazines that act as 5-HT5A antagonists. These antagonists are specifically designed to target and block the serotonin 5-HT5A receptors, playing a significant role in the treatment of mental disorders. N-isopropylpiperidin-4-amine's structural characteristics enable it to form stable and effective antagonists, making it a valuable asset in the development of novel therapeutic agents for mental health.
Check Digit Verification of cas no
The CAS Registry Mumber 534595-53-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,3,4,5,9 and 5 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 534595-53:
(8*5)+(7*3)+(6*4)+(5*5)+(4*9)+(3*5)+(2*5)+(1*3)=174
174 % 10 = 4
So 534595-53-4 is a valid CAS Registry Number.
534595-53-4Relevant academic research and scientific papers
Process for preparing substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds
-
Page/Page column 13, (2008/06/13)
Processes and intermediates for preparing substituted 4-amino-1-(pyridylmethyl)-piperidine and related compounds in high yield and high purity are described. The substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds prepared by the describ
NAPHTHALENE-1,5-DISULFONIC ACID SALTS OF A SUBSTITUTED 4-AMINO-1-(PYRIDYLMETHYL)PIPERIDINE COMPOUND
-
Page/Page column 29-30, (2010/02/11)
This invention provides naphthalene-1,5-disulfonic acid salts of 4-{N-[7-(3-(S)-1-carbamoyl-1,1-diphenylmethyl)pyrrolidin-1-yl)hept-1-yl]-N-(isopropyl)amino}-1-(4-methoxypyrid-3-ylmethyl)piperidine, which salts are useful as muscarinic receptor antagonists. This invention is also directed to pharmaceutical compositions comprising these salt forms, methods of using these salt forms for treating medical conditions mediated by muscarinic receptors; and processes for preparing these salt forms.
